Format
Sort by
Items per page

Send to

Choose Destination

Best matches for hpv vaccine adverse effects:

Search results

Items: 1 to 20 of 1004

1.

Decline in HPV-vaccination uptake in Denmark - the association between HPV-related media coverage and HPV-vaccination.

Suppli CH, Hansen ND, Rasmussen M, Valentiner-Branth P, Krause TG, Mølbak K.

BMC Public Health. 2018 Dec 10;18(1):1360. doi: 10.1186/s12889-018-6268-x.

2.

Autonomic dysfunction and HPV immunization: an overview.

Blitshteyn S, Brinth L, Hendrickson JE, Martinez-Lavin M.

Immunol Res. 2018 Nov 27. doi: 10.1007/s12026-018-9036-1. [Epub ahead of print] Erratum in: Immunol Res. 2018 Dec 21;:.

PMID:
30478703
3.

HPV vaccine and autoimmune diseases: systematic review and meta-analysis of the literature.

Genovese C, LA Fauci V, Squeri A, Trimarchi G, Squeri R.

J Prev Med Hyg. 2018 Sep 28;59(3):E194-E199. doi: 10.15167/2421-4248/jpmh2018.59.3.998. eCollection 2018 Sep.

4.

Amount of Narratives Used on Japanese Pro- and Anti-HPV Vaccination Websites: A Content Analysis

Okuhara T, Ishikawa H, Okada M, Kato M, Kiuchi T.

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2691-2694.

5.

When to include clinical study reports and regulatory documents in systematic reviews.

Jefferson T, Doshi P, Boutron I, Golder S, Heneghan C, Hodkinson A, Jones M, Lefebvre C, Stewart LA.

BMJ Evid Based Med. 2018 Dec;23(6):210-217. doi: 10.1136/bmjebm-2018-110963. Epub 2018 Oct 11.

PMID:
30309870
6.

The effect of exercise on local and systemic adverse reactions after vaccinations - Outcomes of two randomized controlled trials.

Lee VY, Booy R, Skinner SR, Fong J, Edwards KM.

Vaccine. 2018 Nov 12;36(46):6995-7002. doi: 10.1016/j.vaccine.2018.09.067. Epub 2018 Oct 6.

PMID:
30301642
7.

Recurrent respiratory papillomatosis: update 2018.

Derkay CS, Bluher AE.

Curr Opin Otolaryngol Head Neck Surg. 2018 Dec;26(6):421-425. doi: 10.1097/MOO.0000000000000490.

PMID:
30300210
8.

Human papilloma virus genotype distribution and risk factor analysis amongst reproductive-age women in urban Gambia.

Bah Camara H, Anyanwu M, Wright E, Kimmitt PT.

J Med Microbiol. 2018 Nov;67(11):1645-1654. doi: 10.1099/jmm.0.000848. Epub 2018 Oct 9.

PMID:
30299238
9.

Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.

Islam JY, Hoyt AM, Ramos S, Morgan K, Kim CJ, de Sanjose S, Butera N, Senkomago V, Richter KL, McDonald MA, Vielot NA, Smith JS.

Cancer Causes Control. 2018 Nov;29(11):1115-1130. doi: 10.1007/s10552-018-1085-1. Epub 2018 Oct 4.

PMID:
30284670
10.

Evaluation of a 9-valent HPV vaccine in Sprague-Dawley rats: Nonclinical studies assessing general, reproductive, and developmental toxicity.

Wise LD, Wolf JJ, Plitnick LM.

Vaccine. 2018 Oct 15;36(43):6401-6407. doi: 10.1016/j.vaccine.2018.08.071. Epub 2018 Sep 17.

PMID:
30236634
11.

Examining determinants for reporting suspected adverse events following HPV vaccination in Denmark.

Ulendorf Jacobsen S, Valentiner-Branth P, Mølbak K.

Vaccine. 2018 Oct 1;36(41):6158-6162. doi: 10.1016/j.vaccine.2018.08.061. Epub 2018 Sep 7.

PMID:
30201304
12.

Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques.

Ragonnaud E, Schroedel S, Mariya S, Iskandriati D, Pamungkas J, Fougeroux C, Daradoumis J, Thomsen AR, Neukirch L, Ruzsics Z, Salomon M, Thirion C, Holst PJ.

Vaccine. 2018 Oct 1;36(41):6212-6222. doi: 10.1016/j.vaccine.2018.07.075. Epub 2018 Sep 3.

PMID:
30190120
13.

Update From the Advisory Committee on Immunization Practices.

O'Leary ST, Campbell JD, Kimberlin DW.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):270-274. doi: 10.1093/jpids/piy070.

PMID:
30113691
14.

Update From the Advisory Committee on Immunization Practices.

O'Leary ST, Kimberlin DW.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):181-187. doi: 10.1093/jpids/piy050.

PMID:
29961833
15.

Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh.

Salwa M, Abdullah Al-Munim T.

BMC Med Ethics. 2018 Jun 15;19(Suppl 1):39. doi: 10.1186/s12910-018-0287-0.

16.

Discrepancies in the evaluation of the safety of the human papillomavirus vaccine.

Cervantes JL, Doan AH.

Mem Inst Oswaldo Cruz. 2018;113(8):e180063. doi: 10.1590/0074-02760180063. Epub 2018 May 28.

17.

Expanded table: some vaccines recommended for use in adults.

[No authors listed]

Med Lett Drugs Ther. 2018 May 7;60(1546):e82-e85. No abstract available.

PMID:
29746448
18.

Adult immunization.

[No authors listed]

Med Lett Drugs Ther. 2018 May 7;60(1546):73-82. No abstract available.

PMID:
29746447
19.

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Arbyn M, Xu L, Simoens C, Martin-Hirsch PP.

Cochrane Database Syst Rev. 2018 May 9;5:CD009069. doi: 10.1002/14651858.CD009069.pub3. Review.

PMID:
29740819
20.

Face-to-face interventions for informing or educating parents about early childhood vaccination.

Kaufman J, Ryan R, Walsh L, Horey D, Leask J, Robinson P, Hill S.

Cochrane Database Syst Rev. 2018 May 8;5:CD010038. doi: 10.1002/14651858.CD010038.pub3. Review.

PMID:
29736980

Supplemental Content

Loading ...
Support Center